The Metabolic Effects of Ginseng Oligopeptide Preparation on Non- Alcoholic Fatty Liver Disease With Obesity: a Randomized Controlled Double-blind Trial

Exclusion Criteria

• •Under 18 years old and over 65 years old;
• •Allergic to the ingredients of ginseng oligopeptide preparation;
• •Serum ALT, AST, GGT\>2ULN;
• •Currently taking oral hepatoprotective drugs such as reduced glutathione, polyene phosphatidylcholine, and silibinin, etc.;
• •Subjects participating in other clinical trials;
• •Pregnant or lactating women;
• •Complicated with serious diseases of the digestive system or other systems, such as chronic gastrointestinal diseases and chronic diseases causing digestive malabsorption,Kidney disease, hematological system or autoimmune diseases;
• •Other populations that were deemed by the investigators to be ineligible for the trial may reduce or complicate enrollment patients with chemotherapy.